Close

Gilead Sciences (GILD) Updates on Study 102 for TAF on HIV-1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. SNAP
9. TMUS
10. GOOGL


Go back to Gilead Sciences (GILD) Updates on Study 102 for TAF on HIV-1
Gilead Sciences (NASDAQ: GILD) Delayed: 65.27 -1.81 (2.7%)
Previous Close $67.08    52 Week High $108.63 
Open $67.47    52 Week Low $71.39 
Day High $67.90    P/E 36.06 
Day Low $65.09    EPS $1.81 
Volume 15,168,929